Prices For COVID-19 Vaccines Are Starting To Come Into Focus Moderna, one of the leading horses in the coronavirus vaccine race, has already made deals at between $32 and $37 a dose for some foreign countries. The U.S. price is expected to be lower.
The Special Sauce That Makes Some Vaccines Work Adjuvants play a crucial role in many vaccines' effectiveness. Some scientists say there needs to be more research into developing a wider variety of adjuvants because of how important they are.
Morning Edition Questions About How Crash Program Is Picking Coronavirus Vaccines To Back As Operation Warp Speed pushes to develop a COVID-19 vaccine in record time, the number of candidates is being narrowed. The factors guiding the decision about which projects to fund is unclear.
Amid High Stakes, China Is Fast-Tracking COVID-19 Vaccine Efforts Experts say the Communist Party sees more at stake than public health. One of the biggest concerns is the economy. China is also looking to defuse criticism over its early handling of the outbreak.
New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial Cambridge, Mass.-based Moderna, Inc., is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be triggering an immune response in test subjects.
Pfizer Begins Coronavirus Vaccine Trial In U.S. The vaccine, developed in a partnership between the pharmaceutical giant and a German biotech company, began trials on Monday with 360 volunteer subjects.
KUOW Newsroom The race for the coronavirus vaccine in Seattle, and the people behind it The race for the coronavirus vaccine in Seattle, and the people behind it. We feature three people on the frontlines of developing a coronavirus vaccine.
Timetable For A Vaccine Against The New Coronavirus? Maybe This Fall Recent advances in biotech make scientists optimistic that they might have a vaccine that has passed basic tests of human safety and efficacy ready to go to clinics as soon as this fall.
Week In Review City growth and city snow this week Bill Radke review the week's news with Eli Sanders, associate editor at The Stanger, Ashley Archibald, reporter for Real Change News, and Karen Weise, tech correspondent for the New York Times.
KUOW Newsroom Seattle Schools to turn away nearly 1,000 students missing vaccine records Seattle Public Schools plans to turn away students who have not met vaccination requirements today.
